We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 28th:
ASLAN Pharmaceuticals Limited : This clinical-stage oncology-focused biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.3% over the last 60 days.
Abercrombie & Fitch Co. (ANF - Free Report) : This specialty retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.8% over the last 60 days.
Advaxis, Inc. (ADXS - Free Report) : This owner and operator of a late-stage biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 28th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 28th:
ASLAN Pharmaceuticals Limited : This clinical-stage oncology-focused biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.3% over the last 60 days.
ASLAN Pharmaceuticals Ltd. Price and Consensus
ASLAN Pharmaceuticals Ltd. price-consensus-chart | ASLAN Pharmaceuticals Ltd. Quote
ASLAN's shares gained 16.9% over the last one month more than S&P 500’s gain of 0.8%. The company possesses a Momentum Score of A.
ASLAN Pharmaceuticals Ltd. Price
ASLAN Pharmaceuticals Ltd. price | ASLAN Pharmaceuticals Ltd. Quote
Abercrombie & Fitch Co. (ANF - Free Report) : This specialty retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.8% over the last 60 days.
Abercrombie & Fitch Company Price and Consensus
Abercrombie & Fitch Company price-consensus-chart | Abercrombie & Fitch Company Quote
Abercrombie's shares gained 19.7% over the last one month. The company possesses a Momentum Score of B.
Abercrombie & Fitch Company Price
Abercrombie & Fitch Company price | Abercrombie & Fitch Company Quote
Advaxis, Inc. (ADXS - Free Report) : This owner and operator of a late-stage biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.
Advaxis, Inc. Price and Consensus
Advaxis, Inc. price-consensus-chart | Advaxis, Inc. Quote
Advaxis’ shares gained 26.3% over the last one month. The company possesses a Momentum Score of A.
Advaxis, Inc. Price
Advaxis, Inc. price | Advaxis, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>